PEN
Companies
Nyse American
Penumbra Inc.
Health Care
$260.98
+$15.76 (+6.64%)
Price Chart
Overview
About PEN
penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.
Market Cap
$7.3B
Volume
115.1M
Avg. Volume
111.2M
P/E Ratio
67.67725
Dividend Yield
0.00%
Employees
3.3K
Company Information
Risk & Correlation Analysis
Market Correlation
1.06
Moderate Correlation
Volatility
High (0.40)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, PEN shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$7.3B
Volume115.1M
P/E Ratio67.68
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
April 24, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025